Skip to main content

Retail Clinics

  • Prime Therapeutics finds increase in long-acting opioid claims

    ST. PAUL, Minn. — Pharmacy benefit manager Prime Therapeutics recently analyzed pharmacy claims for short- and long-acting opioids, finding a decrease in short-acting opioid claims and an increase in long-acting opioid claims. The review of 15 million commercially insured members found an overall 3.9% decrease in opioid claims from 2014 to 2015. 
     
  • Kaloroma: Retail clinics represent big business for IVD products, POC testing

    NEW YORK - With the number of U.S. clinics located within retail locations exceeding 2,000, they have become an important target for in vitro diagnostic products and point-of-care testing, Kalorama Information reported Wednesday.


  • FDA approves Janssen’s Invokamet XR

    SILVER SPRING, Md. — The Food and Drug Administration has approved Janssen Pharmaceuticals’ Invokamet XR, a once-daily, extended-release combination therapy of Invokana (canagliflozin) and metformin, the company announced Wednesday. The drug is indicated as a first-line treatment to improve blood glucose control in adults with Type 2 diabetes alongside diet and exercise. 
     
  • Pfizer launches Moodivator app for patients with depression

    NEW YORK — Pfizer has launched a new app, Moodivator, aimed at helping to motivate and encourage patients with depression. The app is designed to help patients track their mood, set goals and establish routines as a complement to their treatment for depression, which can include talk therapy, medication and other approaches. 
     
  • Kmart survey reveals shopper insights regarding flu shots

    HOFFMAN ESTATES, Ill. -- In an effort to encourage vaccinations, Kmart has unveiled data from a new survey showing that one in four Americans believe getting the flu vaccine early is the best way to avoid getting sick.

    A new online survey of Kmart shoppers, conducted on behalf of Kmart Pharmacy by the company's Member Feedback and Insights team, found that more than a third of shoppers choose not to get a flu shot, and almost a quarter said that price plays a significant role when deciding if they should get vaccinated.

  • PhRMA, Lupus Foundation report highlights autoimmune drug development

    WASHINGTON — A new report from the Pharmaceutical Research and Manufacturers of America (PhRMA) and the Lupus Foundation of America is highlighting work being done by biopharmaceutical researchers to treat autoimmune diseases. According to the report, some 311 medicines and vaccines for autoimmune diseases are either in clinical trials or awaiting Food and Drug Administration approval.
     
X
This ad will auto-close in 10 seconds